Invega Interactions
There are 629 drugs known to interact with Invega (paliperidone), along with 16 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 118 are major, 509 are moderate, and 2 are minor.
- View all 629 medications that may interact with Invega
- View Invega alcohol/food interactions (4)
- View Invega disease interactions (16)
Most frequently checked interactions
View interaction reports for Invega (paliperidone) and the medicines listed below.
- Abilify (aripiprazole)
- Adderall (amphetamine / dextroamphetamine)
- Ativan (lorazepam)
- benztropine
- clonazepam
- clonidine
- Cymbalta (duloxetine)
- Depakote (divalproex sodium)
- gabapentin
- Geodon (ziprasidone)
- hydroxyzine
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- lamotrigine
- Latuda (lurasidone)
- levothyroxine
- Lexapro (escitalopram)
- lisinopril
- lithium
- lorazepam
- metformin
- omeprazole
- propranolol
- Prozac (fluoxetine)
- Seroquel (quetiapine)
- trazodone
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zoloft (sertraline)
- Zyprexa (olanzapine)
Invega alcohol/food interactions
There are 4 alcohol/food interactions with Invega (paliperidone).
Invega disease interactions
There are 16 disease interactions with Invega (paliperidone) which include:
- dementia
- QT Prolongation
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- priapism
- weight gain
- depression
- hyperprolactinemia
- tardive dyskinesia
- antiemetic effect
- gastrointestinal obstruction
Report options
QR code containing a link to this page
More about Invega (paliperidone)
- Invega consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (233)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
